PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.57%
Negative revenue growth while 2127.T stands at 74.32%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.27%
Negative gross profit growth while 2127.T is at 87.23%. Joel Greenblatt would examine cost competitiveness or demand decline.
-27.63%
Negative EBIT growth while 2127.T is at 130.80%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-30.80%
Negative operating income growth while 2127.T is at 136.77%. Joel Greenblatt would press for urgent turnaround measures.
-28.44%
Negative net income growth while 2127.T stands at 130.75%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-28.45%
Negative EPS growth while 2127.T is at 132.18%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-28.45%
Negative diluted EPS growth while 2127.T is at 132.18%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.76%
10Y revenue/share CAGR 1.25-1.5x 2127.T's 59.45%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
86.76%
5Y revenue/share CAGR 1.25-1.5x 2127.T's 59.45%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
54.48%
3Y revenue/share CAGR under 50% of 2127.T's 137.85%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
206.94%
Net income/share CAGR above 1.5x 2127.T's 109.24% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
206.94%
5Y net income/share CAGR above 1.5x 2127.T's 109.24%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
61.89%
Below 50% of 2127.T's 333.41%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
126.07%
Equity/share CAGR of 126.07% while 2127.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
126.07%
Equity/share CAGR of 126.07% while 2127.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.28%
Inventory growth of 22.28% while 2127.T is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
6.72%
Asset growth well under 50% of 2127.T's 13.83%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.46%
50-75% of 2127.T's 9.35%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-18.56%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.